Astra Plunges After Setback In Crucial Lung Cancer Drug Test (1)

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

Source : https://www.bloomberg.com/news/articles/2017-07-27/astra-s-imfinzi-combination-fails-to-check-lung-tumor-growth

AstraZeneca Plunges After Setback in Crucial Lung-Cancer Drug Trial
Astra Plunges After Setback in Crucial Lung-Cancer Drug Test (1)
The skeptics were right: Bristol-Myers has pulled a crucial Opdivo lung filing as it awaits more data
The 'triple threat' cancer capsule that can navigate itself towards tumours before exploding and releasing drugs
AstraZeneca gets much-needed boost from successful trials of new cancer drugs in the aftermath of Pfizer's failed takeover bid
Drugs giant AstraZeneca plummets in value by £7bn after key lung cancer treatment flops tests
Woodford backs AstraZeneca after Mystic crash
Astra Doubles Down on Cancer Research Despite Key Trial Setback
Astra Zeneca CEO Pascal Soriot says 'we'll sell to Pfizer if the price is right'
Drugs giant AstraZeneca plummets in value by £7bn after key lung cancer treatment flops tests